Prepare Your Fresh Excuses!
- Thread starter yyz
- Start date
Dr Robert Malone Pfizer mRNA "Shot" Inventor Explains - (SURPRISE) The Media Are Lying About Pfizers FDA Approval
<iframe width="450" height="351" src="https://www.youtube.com/embed/OSZE3ceJDec" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
Not so fast YYZ, you've been LIED to.
<iframe width="450" height="351" src="https://www.youtube.com/embed/OSZE3ceJDec" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
Not so fast YYZ, you've been LIED to.
Any of you anti-vaxxers taking Ivermectin? It's supposed to be very effective........for deworming horses.
Ivermectin Discoverers Won the Nobel Prize and It Beats COVID-19
May 11, 2021 by John Venlet
https://freemenfreeminds.us/2021/05...rs-won-the-nobel-prize-and-it-beats-covid-19/
Did you know that the discoverers of Ivermectin, which I?ve mentioned here on a number of occasions, and which I dose myself with as a prophylactic measure against contracting COVID-19 the Chinese batflu, won a Nobel Prize in Medicine in 2015? I just found this out myself.
Ivermectin, Drug for Parasitic Diseases Developed by Nobel Prize Winners, Could Also Control Malaria
Not only is Ivermectin Nobel Prize worthy for its ability to prevent parasitic diseases. It can prevent your contracting COVID-19 the Chinese batflu (go read some of the previous posts here on Ivermectin?s effectiveness ? don?t just take my word for it).
If you want to read something one could almost equate to a miraculous occurrence in regards to the discovery of Ivermectin, click that link. A short excerpt:
?What do penicillin, aspirin and ivermectin have in common? Apart from the fact that they rhyme, all three belong to a very select group of drugs that can claim to have had the greatest beneficial impact on the health and well-being of humanity.??
Because of its impact, safety and versatility, ivermectin has earned the title of ?wonder drug? among public health specialists. Treating entire communities with the drug could represent a safe and effective means of ?hitting several birds with one stone?;
Be a free man, and free your mind from the evils being inflicted on you by governments, so-called medical experts, and the fear mongering media in regards to COVID-19 the Chinese batflu.
Has the hydroxychloroquine unicorn left the room?
Oh, and Kulnik? Take as much Ivermectin as can. You should be fine, since you're a horse's ass!
:lol:
Oh, and Kulnik? Take as much Ivermectin as can. You should be fine, since you're a horse's ass!
:lol:
"You are not a cow", our would-be masters tell us. What they don't say is what they are really thinking, "You are a sheep."
Here in Florida, for some months now, you will be prescribed Ivermectin in pill form the minute you test postive for the Chicom virus. What do these geniuses have to say about that, besides nothing?
The nation of India has also been using Ivermectin to curtail the widespread of C-19 in their country. No comments from these self-appointed godheads on that, either.
Doom on these self-serving bastards. Bloody, screaming doom.
Republicans: "I'm not getting vaccinated because I'm not a sheep"
Also Republicans: "How can I get some of that Hydroxychloroquine and Ivermectin everyone's talking about?"
Also Republicans: "How can I get some of that Hydroxychloroquine and Ivermectin everyone's talking about?"
I would rather take an Established Drug than a Experimental Vaccine.
Hope you Wake Up.
Baaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa.
FDA fraudulently grants full approval to Comirnaty covid vaccine, skipping stage 3 trials and ignoring VAERS data
The U.S. Food and Drug Administration (FDA) has announced its approval for a Wuhan coronavirus (Covid-19) ?vaccine,? which will now be marketed under the name ?Comirnaty.? This is not the same as the Pfizer vaccine, which the media is widely reporting as having received ?full approval.?..
All individuals 16 years of age and older now qualify for injection with the experimental jab from Pfizer-BioNTech, which contains mRNA gene therapy chemicals that do not prevent disease ? this means it is not a true vaccine ? but rather helps to minimize symptoms, supposedly..
Covid mRNA injections deliver spike proteins directly into healthy cells
The newly released package insert further explains that the nucleoside-modified mRNA in Comirnaty is formulated in lipid particles, ?which enable delivery of the mRNA into host cells to allow expression of the SARS-CoV-2 S antigen.?
?The vaccine elicits an immune response to the S antigen, which protects against COVID-19,? the company further claims.
It is important to keep in mind that the injection has not yet even entered Stage 3 trials, despite its approval and despite the fact that it has already been administered more than 200 million times.
more
[link to www.naturalnews.com (secure)]
The U.S. Food and Drug Administration (FDA) has announced its approval for a Wuhan coronavirus (Covid-19) ?vaccine,? which will now be marketed under the name ?Comirnaty.? This is not the same as the Pfizer vaccine, which the media is widely reporting as having received ?full approval.?..
All individuals 16 years of age and older now qualify for injection with the experimental jab from Pfizer-BioNTech, which contains mRNA gene therapy chemicals that do not prevent disease ? this means it is not a true vaccine ? but rather helps to minimize symptoms, supposedly..
Covid mRNA injections deliver spike proteins directly into healthy cells
The newly released package insert further explains that the nucleoside-modified mRNA in Comirnaty is formulated in lipid particles, ?which enable delivery of the mRNA into host cells to allow expression of the SARS-CoV-2 S antigen.?
?The vaccine elicits an immune response to the S antigen, which protects against COVID-19,? the company further claims.
It is important to keep in mind that the injection has not yet even entered Stage 3 trials, despite its approval and despite the fact that it has already been administered more than 200 million times.
more
[link to www.naturalnews.com (secure)]
WARNING - FDA Report Shows Proof New Pfizer COMIRNATY Covid Vaccine They Approved Is Different And It's Potential Dangers
I found the FDA Report for the "approved" Covid Pfizer vaccine from Pfizer. Warning, it is a different vaccine than the current one available. It's called Comirnaty and they have yet to release it! Do not be fooled by mainstream media or other people that do not do the research. Here is the link from the FDA for the report.
FDA Report - Approval For Pfizer COMIRNATY Vaccine (Summary Basis for Regulatory Action)
[link to www.fda.gov (secure)]
(The report is 33 pages long! I copied some of the details I found that may be concerning and listed them here.)
**Nonclinical Toxicology** (page 14 - Proof Pfizer Comirnaty and the currently available Pfizer BioNTech BNT162b2 vaccine are TWO DIFFERENT VACCINES - THIS IS WHY THE CURRENT PFIZER VACCINE IS NOT FDA APPROVED AND NOT RELEASED YET)
The repeat dose toxicity evaluations were conducted on COMIRNATY and a similar vaccine termed BNT162b2 (V8). COMIRNATY and BNT162b2 (V8) have identical amino acid sequences of the encoded antigens but COMIRNATY includes the presence of optimized codons to improve antigen expression.
**Myocarditis/Pericarditis** (page 23)
Post-EUA safety surveillance reports received by FDA and CDC identified serious risks for myocarditis and pericarditis following administration of COMIRNATY. Reporting rates for medical chart-confirmed myocarditis/pericarditis in VAERS have been higher among males under 40 years of age than among females and older males and have been highest in males 12-17 years of age (65 cases per million doses administered as per CDC communication on August 20, 2021), particularly following the second dose, and onset of symptoms within 7 days following vaccination. Although some cases of vaccine- associated myocarditis/pericarditis required intensive care support, available data from short-term follow up suggest that most individuals have had resolution of symptoms with conservative management. Information is not yet available about potential long-term sequelae and outcomes in affected individuals. A mechanism of action by which the vaccine could cause myocarditis and pericarditis has not been established.
These safety findings of increased risk for myocarditis/pericarditis led to warning in section 5.2 Warning and Precautions of the PI.. Moreover, since vaccine-associated myocarditis/pericarditis is the most clinically significant identified risk, FDA undertook a quantitative benefit-risk assessment to model the excess risk of myocarditis/pericarditis vs. the expected benefits of preventing COVID- 19 and associated hospitalizations, ICU admissions, and deaths.
**Advisory Committee Meetings** (page 26)
Vaccines and Related Biological Products Committee (VRBPAC) meetings were convened on October 22, 2020 to discuss, in general, development for EUA and licensure of vaccines to prevent COVID-19 and on December 10, 2020, to discuss BioNTech Manufacturing GmbH/Pfizer?s EUA request for the Pfizer-BioNTech COVID-19 Vaccine.
The VRPBAC voted on one question:
1. Based on the totality of scientific evidence available, do the benefits of the Pfizer- BioNTech COVID-19 Vaccine outweigh its risks[u/] for use in individuals 16 years of age and older?
The results of the vote were as follows:
Yes = 17 No = 4 Abstain = 1
**Post-Marketing Requirements Under Section 505(o)** (page 33)
Study C4591009, entitled ?A Non-Interventiona lPost-Approval Safety Study of the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States,? to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY.
Final Protocol Submission: August 31, 2021
Monitoring Report Submission: October 31, 2022
Interim Report Submission: October 31, 2023
Study Completion: June 30, 2025
Final Report Submission: October 31, 2025
The FDA will not get the final Safety Report on the occurrence of myocarditis and pericarditis for 4 more years!
Post-Marketing Commitments Subject To Reporting Requirements Under Section 506B (page 29)
Study C4591022, entitled ?Pfizer-BioNTech COVID-19 Vaccine Exposure during Pregnancy: A Non-Interventional Post-Approval Safety Study of Pregnancy and Infant Outcomes in the Organization of Teratology Information Specialists (OTIS)/Mother To Baby Pregnancy Registry?
Final Protocol Submission: July 1, 2021
Study Completion: June 1, 2025
Final Report Submission: December 1, 2025
The FDA will not get the final Safety Report For Pregnancy and Infant Outcomes for 4 more years!
I found the FDA Report for the "approved" Covid Pfizer vaccine from Pfizer. Warning, it is a different vaccine than the current one available. It's called Comirnaty and they have yet to release it! Do not be fooled by mainstream media or other people that do not do the research. Here is the link from the FDA for the report.
FDA Report - Approval For Pfizer COMIRNATY Vaccine (Summary Basis for Regulatory Action)
[link to www.fda.gov (secure)]
(The report is 33 pages long! I copied some of the details I found that may be concerning and listed them here.)
**Nonclinical Toxicology** (page 14 - Proof Pfizer Comirnaty and the currently available Pfizer BioNTech BNT162b2 vaccine are TWO DIFFERENT VACCINES - THIS IS WHY THE CURRENT PFIZER VACCINE IS NOT FDA APPROVED AND NOT RELEASED YET)
The repeat dose toxicity evaluations were conducted on COMIRNATY and a similar vaccine termed BNT162b2 (V8). COMIRNATY and BNT162b2 (V8) have identical amino acid sequences of the encoded antigens but COMIRNATY includes the presence of optimized codons to improve antigen expression.
**Myocarditis/Pericarditis** (page 23)
Post-EUA safety surveillance reports received by FDA and CDC identified serious risks for myocarditis and pericarditis following administration of COMIRNATY. Reporting rates for medical chart-confirmed myocarditis/pericarditis in VAERS have been higher among males under 40 years of age than among females and older males and have been highest in males 12-17 years of age (65 cases per million doses administered as per CDC communication on August 20, 2021), particularly following the second dose, and onset of symptoms within 7 days following vaccination. Although some cases of vaccine- associated myocarditis/pericarditis required intensive care support, available data from short-term follow up suggest that most individuals have had resolution of symptoms with conservative management. Information is not yet available about potential long-term sequelae and outcomes in affected individuals. A mechanism of action by which the vaccine could cause myocarditis and pericarditis has not been established.
These safety findings of increased risk for myocarditis/pericarditis led to warning in section 5.2 Warning and Precautions of the PI.. Moreover, since vaccine-associated myocarditis/pericarditis is the most clinically significant identified risk, FDA undertook a quantitative benefit-risk assessment to model the excess risk of myocarditis/pericarditis vs. the expected benefits of preventing COVID- 19 and associated hospitalizations, ICU admissions, and deaths.
**Advisory Committee Meetings** (page 26)
Vaccines and Related Biological Products Committee (VRBPAC) meetings were convened on October 22, 2020 to discuss, in general, development for EUA and licensure of vaccines to prevent COVID-19 and on December 10, 2020, to discuss BioNTech Manufacturing GmbH/Pfizer?s EUA request for the Pfizer-BioNTech COVID-19 Vaccine.
The VRPBAC voted on one question:
1. Based on the totality of scientific evidence available, do the benefits of the Pfizer- BioNTech COVID-19 Vaccine outweigh its risks[u/] for use in individuals 16 years of age and older?
The results of the vote were as follows:
Yes = 17 No = 4 Abstain = 1
**Post-Marketing Requirements Under Section 505(o)** (page 33)
Study C4591009, entitled ?A Non-Interventiona lPost-Approval Safety Study of the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States,? to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY.
Final Protocol Submission: August 31, 2021
Monitoring Report Submission: October 31, 2022
Interim Report Submission: October 31, 2023
Study Completion: June 30, 2025
Final Report Submission: October 31, 2025
The FDA will not get the final Safety Report on the occurrence of myocarditis and pericarditis for 4 more years!
Post-Marketing Commitments Subject To Reporting Requirements Under Section 506B (page 29)
Study C4591022, entitled ?Pfizer-BioNTech COVID-19 Vaccine Exposure during Pregnancy: A Non-Interventional Post-Approval Safety Study of Pregnancy and Infant Outcomes in the Organization of Teratology Information Specialists (OTIS)/Mother To Baby Pregnancy Registry?
Final Protocol Submission: July 1, 2021
Study Completion: June 1, 2025
Final Report Submission: December 1, 2025
The FDA will not get the final Safety Report For Pregnancy and Infant Outcomes for 4 more years!
<blockquote class="twitter-tweet"><p lang="en" dir="ltr">The FDA's "authorization" of the Pfizer "vaccine" isn't really an authorization. <a href="https://t.co/tbDDIe5XT7">pic.twitter.com/tbDDIe5XT7</a></p>— Ed Rankin, PhD (@EdwinRankin) <a href="https://twitter.com/EdwinRankin/status/1431714769623523328?ref_src=twsrc%5Etfw">August 28, 2021</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
